Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
3.770
0.00 (0.00%)
Jun 20, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Anti-tumor | 1.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-tumor Growth | -3.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical | 458.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Growth | 0.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gynecological drugs | 290.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gynecological drugs Growth | 2.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular | 283.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular Growth | -9.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 12.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | 108.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 544.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 34.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Prescription | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Prescription Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Over-the-counter | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Over-the-counter Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 2.82B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 3.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|